Growth of the US Healthcare Advertising Market Induced by New Drug Launches and Rising Patent Expirations

In the recent past, growing popularity of various digital platforms have brought about the integration of marketing and healthcare. As a result, healthcare corporations are increasing their expenditure on advertising through various channels like television, print ads, social media, detailing, etc.

A recently released report by IMARC Group titled “US Healthcare Advertising Market Report & Forecast: 2016-2021” comprehensively discusses the US healthcare advertising market. The report finds that unlike advertising in other industries, healthcare advertising is very different and has multiple layers of regulations. Advertising in the healthcare sector is subjected to regulations not just by the Federal Trade Commission and state consumer protection agencies but also by a host of other regulatory bodies. The report states that the healthcare spending in the US is far greater than other countries. Currently, the US has one of the highest per capita expenditure on healthcare with estimates suggesting that by 2020, it will spend approximately 28% of its GDP on healthcare.

In the recent past, growing popularity of various digital platforms have brought about the integration of marketing and healthcare. As a result, healthcare corporations are increasing their expenditure on advertising through various channels like television, print ads, social media, detailing, etc. The report provides a detailed insight into the various trends that are currently shaping the healthcare advertising market in the US. Some of the major factors driving this market include an increase in the number of new drug launches and a rise in the manufacturing of generic and me-too drugs which have resulted in an increasing need for promotional activities. Further, growing consumer demand for educational content in the form of blogs, social media, white papers, videos, emails, etc. has led to an increase in Direct-to-Consumer advertising which is ultimately stimulating the growth of the US healthcare advertising market. Other factors such as aging population, high purchasing power, growing number of health conscious consumers and an increasing prevalence of lifestyle diseases have also contributed to the growth of this market.

Enquiry for sample report or more details, click here: http://www.imarcgroup.com/request?type=report&id=723&flag=B

The report provides the market analysis on the basis of key segments which include the Pharmaceutical (small molecule drugs) Market, Biopharmaceutical Market, Vaccines Market and Over-the-Counter (OTC) Drugs Market in the US. For each of the healthcare segments, the report provides the share of various channels such as Detailing, Sampling, Direct-to-Consumer (DTC), Mailing/E-Mailing, Print Advertising, etc. The report finds that Detailing represents the most preferred mode of promotion among the other healthcare segments. The report has also covered major players operating in the US healthcare advertising market which include Johnson & Johnson, Pfizer, Merck, GlaxoSmithKline and Roche.

This report provides an analytical and statistical insight into the advertising trends in the healthcare sector in the US. The market analysis includes market trends, key players in the healthcare sector, sales and advertising trends in the different sectors, breakup by advertising channels, etc. The study, which is based both on desk research and multiple waves of qualitative primary research, is a must-read for entrepreneurs, investors, researchers, consultants, business strategists and all those who are planning to foray into advertising in the US healthcare industry in any manner.

Browse full report on US Healthcare Advertising Market: http://www.imarcgroup.com/us-healthcare-advertising-market

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC Group
671 North Randolph Street,
Arlington, VA 22203, United States
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal

This release was published on openPR.